Polyplus-transfection SA, has announced that ExcellGene SA has signed an extended supply agreement for Polyplus-transfection polyethylenimine (PEI) based transfection reagents. Polyplus-transfection ...
Polyplus-transfection has granted Merck rights to the prior use of PEI for transfection. Polyplus-transfection will also supply Merck sites worldwide with batches of high quality linear PEI ...
PEI transfection reagents are designed to enable protein production in the medium-to-large scale ranges. ExcellGene, a provider of solutions for protein manufacturing and process development based on ...
Polyplus-transfection SA, a privately-held company developing innovative technologies for molecular and cellular biology, and Blue Sky BioServices, a contract research organization (CRO) providing ...
L-22 kDa, B-25 kDa PEI and DCChol/DOPE lipoplexes were evaluated for luciferase reporter gene delivery to the mouse airways (Figure 2). The L-22 kDa PEI gave consistently higher gene expression than ...
Response Surface Methods Point the Way to Higher rAAV Yields at Lower Levels of Transfection Reagent
Adverum Biotechnologies describes a multifactor design of experiments methodology that can optimize rAAV vector production while maintaining a specified N/P ratio Researchers at Adverum ...
Accurate monitoring of nanoparticle size and growth is essential to ensure scalability in the development of transfection vectors for gene delivery. This study highlights how Spatially Resolved-DLS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback